Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.34% | 178.12 | 0.7% | $1344.93m | |
| MRK | Merck & Co., Inc. | 0.55% | 91.67 | 0.7% | $1174.23m | |
| PFE | Pfizer Inc. | -1.08% | 51.87 | 0.9% | $1101.79m | |
| LLY | Eli Lilly & Co. | -0.91% | 321.27 | 1.1% | $1036.13m | |
| BMY | Bristol-Myers Squibb Co. | -1.00% | 76.23 | 1.0% | $997.78m | |
| ABBV | AbbVie, Inc. | -0.59% | 152.25 | 1.9% | $953.03m | |
| AZN | AstraZeneca Plc | -1.00% | 65.41 | 1.0% | $437.07m | |
| SGEN | Seagen Inc. | 0.90% | 178.54 | 5.7% | $318.75m | |
| TPTX | Turning Point Therapeutics, Inc. | -0.12% | 75.16 | 0.0% | $287.74m | |
| GSK | GSK Plc | -0.15% | 43.47 | 0.2% | $276.07m | |
| HZNP | Horizon Therapeutics Plc | 1.04% | 80.59 | 5.4% | $163.49m | |
| NVS | Novartis AG | -0.91% | 83.76 | 0.2% | $163.07m | |
| MRTX | Mirati Therapeutics, Inc. | 2.96% | 69.12 | 1.6% | $151.06m | |
| NVO | Novo Nordisk A/S | -0.54% | 110.83 | 0.1% | $142.45m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.17% | 145.47 | 0.0% | $142.09m |
Company Profile
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma. The company was founded in October 2004 and is headquartered in San Diego, CA.